Does "Arcturus" COVID variant cause pink eye? What officials say
The CDC estimates that XBB.1.16 is now more than 1 in 10 infections.
Alexander Tin is a digital reporter for CBS News based in the Washington, D.C. bureau. He covers the Biden administration's public health agencies, including the federal response to infectious disease outbreaks like COVID-19. Previously, he was a campaign reporter for CBS News based out of Las Vegas, where he was raised. He covered presidential, Senate and House candidates for the 2020 election cycle in Arizona, California, Nevada and New Mexico. He has also worked in Washington for "Face the Nation" and in New York for the "CBS Evening News." Tin graduated from Columbia University in 2017 with a bachelor's degree in political science.
The CDC estimates that XBB.1.16 is now more than 1 in 10 infections.
Health authorities in southern Nevada saw a record 17 cases during 2022.
The drugmaker says the FDA could clear the new COVID drug for immunocompromised in months.
Experts and health authorities have long urged parents to ensure their children are eating breakfast daily.
The Biden administration has extended the requirement only through May 11.
Researchers have theorized that "network immunity" helped slow the global outbreak.
The CDC estimated last week that XBB.1.16 was around 9.6% of new infections.
The latest round of boosters comes amid a swath of changes now greenlighted by FDA and CDC to COVID-19 vaccines.
At least one person has died and nearly 100 have been sickened in an outbreak of blastomycosis at a northwest Michigan paper mill.
All cases are among workers, contractors or visitors of a paper and packaging materials plant in the Michigan town of Escanaba, which has now been temporarily shuttered.
Health authorities in Africa have been battling two unprecedented outbreaks of the Ebola-like viral hemorrhagic fever.
Products manufactured by Global Pharma Healthcare Pvt Ltd were linked to a fatal outbreak of drug-resistant bacteria.
Most jurisdictions have low levels of vaccination coverage against the virus formerly known as monkeypox, the CDC says.
Officials say needs have grown to sustain a pipeline of medical products stockpiled for public health threats.
Scientists found a "major reduction" in a part of T cell responses in people who were infected before being vaccinated.